Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.




Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.12
Lead investments 0
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Life Science

Valneva is the famous Corporate Investor, which was founded in 2013. The main office of represented Corporate Investor is situated in the Saint-herblain. The company was established in Europe in France.

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Kurma Partners, Idinvest Partners. In the next rounds fund is usually obtained by Idinvest Partners.

Among the most popular portfolio startups of the fund, we may highlight BliNK Biomedical. Among the most successful fund investment fields, there are Life Science, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - France.

The top activity for fund was in 2014. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Valneva:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
Valneva is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Valneva:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bioclub China, Hangzhou, Zhejiang
Boston Syndicates (BOSS) Boston, Massachusetts, United States
Central Coast Angels California, Santa Cruz, United States
Central Wisconsin Angel Investors Madison, United States, Wisconsin
Currie Capital California, San Francisco, United States
D2 Communications Hokkaido Prefecture, Japan, Sapporo
Finn Capital Partners California, San Francisco, United States
Finn Partners New York, New York, United States
Gaohe Chuangtou China, Hubei, Wuhan
Jiahesheng Maoyi China, Fujian, Zhangpu
MyBey Ventures -
Oaktree Specialty Lending Corp. New York, United States, White Plains
PLG Ventures California, Santa Monica, United States
Shanhua Touzi China, Guangdong, Guangzhou
SINOCHEM GROUP Beijing, Beijing, China
Sundaram Mutual Fund Chennai, India, Tamil Nadu
Taiwan Development Fund -
Underground Printing Ann Arbor, Michigan, United States
Vidici Ventures Stockholm, Stockholm County, Sweden
Weintraub Capital Management California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BliNK Biomedical

Life Science
$4M11 Dec 2014 Lyon, Auvergne-Rhône-Alpes, France


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Valneva?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 4M
Rounds per year 0.12
Peak activity year 2014
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

BliNK Biomedical

Life Science
$4M11 Dec 2014 Lyon, Auvergne-Rhône-Alpes, France

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: